1.The wild-type alpha-synuclein over-expression to induce the protein aberrant aggregation of alpha-synuclein in HEK293 cells in vitro.
Tao CHEN ; Bei-sha TANG ; Xiao-ping LIAO ; Xin-xiang YAN ; Ru-xu ZHANG ; Yu-hu ZHANG ; Jian-guang TANG ; Li CAO ; Ji-feng GUO ; Jing LI
Chinese Journal of Medical Genetics 2006;23(1):19-22
OBJECTIVETo investigate over-expression of wild-type alpha-synuclein inducing the aberrant aggregation of alpha-synuclein in HEK293 cell in vitro.
METHODSThe cDNA encoding the human alpha-synuclein without the stop code was cloned into PGEM T-easy vector. Using enzyme map and DNA sequencing analyzed and determined the recombinant plasmid, and then sub-clone the alpha-synuclein cDNA fragment into pEGFP-N1 vector. The recombinant plasmids alpha-synuclein-pEGFP were transfected into HEK293 cells by lipofectamin 2000. The aberrant aggregation of alpha-synuclein was measured by EGFP fluorescence, anti-alpha-synuclein immunocytochemistry. The inclusions in the cultured cells were identified with HE staining.
RESULTSThe restriction enzyme map suggested that eukaryotic expression vector for human wild-type alpha-synuclein gene was constructed successfully. By EGFP fluorescence, anti-alpha-synuclein immunocytochemistry, it could be observed that the alpha-synuclein protein could aggregate in cytoplasm and the Lewy body-like inclusions found in cytoplasm of cultured cells.
CONCLUSIONThe over-expression of wild-type alpha-synuclein can induce protein aberrant aggregation and Lewy body-like inclusions formation in cytoplasm of HEK293 cell in vitro.
Cells, Cultured ; Gene Expression ; Humans ; Immunohistochemistry ; Inclusion Bodies ; metabolism ; Lewy Bodies ; metabolism ; Parkinson Disease ; genetics ; metabolism ; alpha-Synuclein ; genetics ; metabolism
2.A Case of Adult Polyglucosan Body Disease.
Seung Yeob LEE ; Jae Hyeon PARK ; So Hun KIM ; Tai Seung KIM ; Won Joo KIM ; Young Chul CHOI
Yonsei Medical Journal 2007;48(4):701-703
Adult polyglucosan body disease (APBD) is a rare neurological disease, characterized by adult onset (fifth to seventh decades), progressive sensorimotor or pure motor peripheral neuropathy, upper motor neuron symptoms, neurogenic bladder, and cognitive impairment. APBD is confirmed by a sural nerve biopsy that shows the widespread presence of polyglucosan bodies in the nerve. We report a 70 year old male patient who exhibited progressive weakness in all extremities and dementia. His electrodiagnostic studies showed sensorimotor polyneuropathy and muscle pathology that consisted of polyglucosan bodies located in small peripheral nerves. This is the first case of APBD reported in Korea.
Aged
;
Biopsy
;
*Glucans/metabolism
;
Humans
;
Inclusion Bodies
;
Male
;
Neurodegenerative Diseases/metabolism/*pathology
3.Complex structures and diverse functions of nuclear bodies: a review.
Xinyuan LIU ; Lian-Feng LI ; Hua-Ji QIU
Chinese Journal of Biotechnology 2021;37(7):2223-2231
Nuclear bodies are membrane-free nuclear substructures that are localized in the mammalian nuclear matrix region. They are multiprotein complexes that recruit other proteins to participate in various cellular activities, such as transcription, RNA splicing, epigenetic regulation, tumorigenesis and antiviral defense. It is of great significance to clarify the functions and regulatory mechanisms of nuclear bodies to probe related diseases and virus-host interactions. This review takes several nuclear bodies associated proteins as examples, summarizes the formation process, structure and functions of nuclear bodies, and focuses on their important roles in antiviral infection. It is expected to provide new insight into host antiviral mechanisms.
Animals
;
Cell Nucleus
;
Epigenesis, Genetic
;
Intranuclear Inclusion Bodies/metabolism*
;
Nuclear Proteins/metabolism*
4.Inclusion body fibromatosis: a case report.
Hong GAO ; Xi-yin SUN ; Xiao-qiu ZHOU ; Xin-gong LI
Chinese Journal of Pathology 2006;35(5):316-316
Actins
;
metabolism
;
Female
;
Fibroma
;
metabolism
;
pathology
;
surgery
;
Foot Diseases
;
metabolism
;
pathology
;
Humans
;
Immunohistochemistry
;
Inclusion Bodies
;
metabolism
;
pathology
;
Infant
;
Toes
5.High expression of mirobial transglutaminase gene from Streptoverticillium mobaraense in Escherichia coli.
Bin XU ; Zhi-Bo HAN ; Ping YANG ; Yong-Jun LIU ; Yan-Han LI ; Zhong-Chao HAN
Chinese Journal of Biotechnology 2005;21(5):794-798
The microbial transglutamunase (MTG) gene was amplified from the genomic DNA of Streptoverticillium mobaraensea by using PCR and inserted into pET vector to construct the expression plasmid called pET-MTG. The pET-MTG was transfected into E. coli (Rosetta DE3) and the MTG protein was found to be highly expressed as inclusion bodies. The inclusion bodies were isolated and subjected to denaturation and re-naturation, followed by strong cation ion-exchange chromatography to purify the expressed MTG. The specific activity of purified MTG was close to that of native MTG. Taken together, this study might provide a base for the industrial production of microbial transglutaminase.
Bacterial Proteins
;
genetics
;
metabolism
;
Escherichia coli
;
genetics
;
metabolism
;
Genes, Bacterial
;
Inclusion Bodies
;
enzymology
;
Recombinant Proteins
;
genetics
;
metabolism
;
Streptomycetaceae
;
enzymology
;
genetics
;
Transglutaminases
;
genetics
;
metabolism
6.Prokaryotic expression, purification, refolding and biological assays of recombinant human interleukin 4 inclusion body.
Jiong LI ; Kaijun CUI ; Jing WEN ; Zhiwei ZHAO ; Ping CHEN ; Ling TIAN ; Bing KAN ; Yanjun WEN ; Hongxin DENG ; Linyu FAN ; Yuquan WEI
Journal of Biomedical Engineering 2007;24(4):866-869
A DNA fragment encoding human interleukin 4 was obtained by PCR from pORF-hIL4 plasmid. The amplified fragment was inserted into prokaryotic expression vector PQE60 and recombinant protein was expressed in E. Coli M15 by adding isopropyl-beta-D-thiogalactoside (IPTG). The hIL-4 protein was present as insoluble inclusion bodies in the bacterial extract. After denaturation of inclusion bodies with 5 mol/L guanidine hydrochloride, the supernate was diluted to get renaturized. Then dialysis and Ni chelating chromatography were used for purification. TF-1 proliferation assay of recombinant human interleukin 4 was performed, and then rhIL-4 was fit to be used for proliferation of human dendritic cells from monocyte in vitro.
Escherichia coli
;
genetics
;
metabolism
;
Genetic Vectors
;
Humans
;
Inclusion Bodies
;
metabolism
;
Interleukin-4
;
biosynthesis
;
genetics
;
Protein Folding
;
Recombinant Proteins
;
biosynthesis
;
genetics
;
isolation & purification
7.Expression of goose interleukin-2 gene in Escherichia coli and isolation of its soluble monomer.
Jing QI ; Jigang CHEN ; Jinyong WANG ; Jie FANG ; Jiajun WU ; Jiyong ZHOU
Chinese Journal of Biotechnology 2008;24(2):183-187
Recombinant expression plasmid of pET-28a (+)-goIL-2 was constructed by inserting the goose IL-2 gene without the signal peptide sequence into the prokaryotic expression vector pET-28a (+), and transformed into the bacterial competent E. coli BL21 (DE3) cells for expression. After IPTG induction, an expected protein band with molecular weight of 15.0 kD was observed on SDS-PAGE gel, recognized by monoclonal antibody against goose IL-2 in western-blotting assay. In the pET-28a (+) expression system, much of the recombinant goose IL-2 (rgoIL-2) was found in inclusion bodies with a portion of soluble protein. The monomer and multimers of soluble goose interleukin 2 proteins were observed in native electrophoresis. The rgoIL-2 proteins were purified by Ni-NTA column under a native condition. The rgoIL-2 soluble protein monomer was isolated by a quick protein isolation and purification system of AKTA FPLC and identified by native PAGE. Bioactivity analysis showed that the rgoIL-2 monomer stimulated the proliferation of goose lymphocytes in vitro. This will establish a basis for further study about the biological function and clinical application of goose IL-2.
Animals
;
Escherichia coli
;
genetics
;
metabolism
;
Geese
;
genetics
;
Inclusion Bodies
;
metabolism
;
Interleukin-2
;
biosynthesis
;
genetics
;
Recombinant Proteins
;
biosynthesis
;
genetics
;
isolation & purification
;
Solubility
8.Relationship between the pathologic changes of human embryo fibroblast cells and expression of late mRNA after human cytomegalovirus infection in vitro.
Hui WANG ; Liang-zhen WEN ; Xia-zhen LING
Chinese Journal of Experimental and Clinical Virology 2004;18(4):351-353
OBJECTIVETo study the relationship between late mRNA and the cytopathic effect(CPE) and ultrastructural features after human cytomegalovirus (HCMV) infection in vitro.
METHODSHuman embryo fibroblast cells(HEL) were infected with HCMV AD169 strain. The expression of the HCMV late mRNA was measured by semiquantitative RT-PCR, the cytopathic effect (CPE) and the cell ultrastructure were observed by means of light microscopy and electron microscopy, respectively.
RESULTSThe HCMV late mRNA could be detected 12 hours postinfection and increased gradually, but the CPE appeared 48 hours postinfection in HEL cells. The HCMV infected cells exhibited significant mitochondrial enlargement and the number of mitochondrial ridge deletion, the cisternae lumen of endoplasmic reticulum (ER) dilation and vacuolization (at the end age). The mature nucleocapsid could be observed 96 hours postinfection.
CONCLUSIONThe ultrastructural changes have an intimate correlation with the expression of HCMV late mRNA and play an important role in the life circle of the virus. HCMV late mRNA may serve as a indicator of the clinical effect of treatment in active HCMV infection.
Cytomegalovirus ; genetics ; physiology ; Cytopathogenic Effect, Viral ; Embryo, Mammalian ; Endoplasmic Reticulum ; pathology ; virology ; Fibroblasts ; metabolism ; ultrastructure ; virology ; Humans ; Inclusion Bodies ; pathology ; virology ; Mitochondrial Swelling ; RNA, Messenger ; metabolism
9.Using process of refolding the protein to obtain recombinant human interleukin-1 receptor antagonist.
Shugang LI ; Xiaoyan DENG ; Hong ZHAO ; Xiudong HUANG ; Tinghe YU ; Yong CHENG ; Guoping DAN
Journal of Biomedical Engineering 2007;24(5):1128-1132
Recombinant human interleukin-1 receptor antagonist was expressed in E. coli as an insoluble inclusion body. The inclusion body was dissolved in the 8 M urea and then the solution was diluted untill the concentration of urea became 2 M. By ion exchange chromatography the protein in the solution of 2 M urea was refolded and purified. At last the purity of product is more than 95% and its bioactivity is more than 1 x 10(5) IU/mg while it has little endotoxin. Western-Blotting also indicates that recombinant protein can react with antibodies against anti-hIL-1ra.
Escherichia coli
;
genetics
;
metabolism
;
Humans
;
Inclusion Bodies
;
metabolism
;
Interleukin 1 Receptor Antagonist Protein
;
biosynthesis
;
genetics
;
Protein Folding
;
Recombinant Proteins
;
biosynthesis
;
genetics
;
isolation & purification
10.On-column refolding and purification of human EGF receptor L2 domain inclusion body overexpressed in Escherichia coli.
Li-Hui XU ; An HONG ; Xian-Hui HE
Chinese Journal of Biotechnology 2005;21(4):597-603
The human epidermal growth factor receptor (EGFR) extracellular region (residues 1-621) consists of four subdomains, i.e. L1, S1, L2, and S2. The L2 domain (EGFR-L2) is composed of residues 311-479 and plays a major role in ligand-binding. Due to the high content of cysteine residues (42 cysteines) in the S1 and S2 domains, it is quite difficulty to get a correctly refolded product of the complete EGFR extracellular domain. In contrast, only 4 cysteine residues are present in EGFR-L2 domain. The aim of the present study is to prepare a soluble EGFR-L2 domain from the recombinant protein inclusion body overexpressed in Escherichia coli (E. coli). DNA fragment encoding EGFR-L2 containing a polyhistidine-tag at the carboxyl terminus was amplified by PCR from the cDNA of EGFR extracellular region, and was inserted into pET-3c to construct the prokaryotic expression vector. The target protein was highly expressed in E. coli BL21 (DE3) strain and was only present in the inclusion body as revealed by immunoblotting analysis. No soluble product could be refolded through dilution or stepwise dialysis strategies. However, on-column refolding of denatured EGFR-L2 bound to Ni2+ -NTA produced a soluble one. Furthermore,the soluble EGFR-L2 was simultaneously purified to high purity (>95%) through eluting from the same Ni2+ -NTA column with a linear imidazole gradient. The refolded EGFR-L2 had specific binding activity with the cognate ligand EGF, although its affinity was low. These results suggest that a polyhistidine-tag fused with a recombinant protein facilitate not only the purification but also the renaturation of the target product through on-column refolding. Besides, this refolding strategy may be suitable for the preparation of those recombinant proteins which are hard to refold through conventional approaches.
Escherichia coli
;
genetics
;
metabolism
;
Humans
;
Inclusion Bodies
;
genetics
;
metabolism
;
Protein Folding
;
Receptor, Epidermal Growth Factor
;
biosynthesis
;
genetics
;
isolation & purification
;
Recombinant Fusion Proteins
;
biosynthesis
;
genetics
;
isolation & purification